 Seattle, WA Vancouver, BC , Oct. 26, 2021 GLOBE NEWSWIRE -- Achieve Life Sciences, Inc. Nasdaq: ACHV, a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it will report its third-quarter 2021 financial results and provide an update on the cytisinicline development program on Tuesday, November 9, 2021, at 4:30 PM EST. 